SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR
Strattera is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat children and adults with attention deficit hyperactivity disorder (ADHD). Strattera is sometimes prescribed off-label to treat narcolepsy. Strattera is also referred to by its drug name, atomoxetine hydrochloride.
Strattera belongs to a class of drugs called selective norepinephrine reuptake inhibitors. Strattera is believed to work in cases of narcolepsy by increasing transmission between neurons, increasing attention and alertness.
How do I take it?
Prescribing information states that Strattera is taken once or twice daily.
Strattera comes in capsule form. It should be taken exactly as prescribed by a physician.
The FDA-approved label for Strattera lists common side effects in children and adolescents including nausea, vomiting, fatigue, decreased appetite, and abdominal pain. It also lists common side effects for adults including constipation, dry mouth, nausea, fatigue, decreased appetite, insomnia, erectile dysfunction, urinary problems, loss of menstrual periods, and flushing.
Rare but serious side effects listed for Strattera include suicidal ideation, severe liver injury, and serious heart problems such as sudden stroke or heart attack.
For more details about this treatment, visit:
Strattera — RxList